• Anti-SAP-Antikörper (Richards et al., Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component.
    Richards DB, Cookson LM, Berges AC, Barton SV, Lane T, Ritter JM, Fontana M, Moon JC, Pinzani M, Gillmore JD, Hawkins PN, Pepys MB. N Engl J Med. 2015 Jul 15. [Epub ahead of print]
  • NEOD001: (Gertz et al. Cardiac and renal biomarker responses in a phase 1/2 study of NEOD001 in patients with AL amyloidosis and persistent organ dysfunction. ASCO MEETING ABSTRACTS May 18, 2015:8514